New study suggests apolipoprotein B blood test predicts heart attacks and strokes better

A new study suggests measuring Apolipoprotein B (ApoB) in blood tests could better predict heart attacks and strokes than current cholesterol tests. The research indicates ApoB levels, which count dangerous fat particles, offer a more complete cardiovascular risk assessment than LDL cholesterol alone. This could lead to more effective prevention strategies. This finding aligns with updated medical guidelines that are increasingly recognizing ApoB's importance in managing lipid disorders and guiding treatment decisions for heart health.